Trial Profile
Metacognitive Therapy, Fluvoxamine, or Combination Treatment in Obsessive-Compulsive Disorder: A randomized clinical trial.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Sep 2016
Price :
$35
*
At a glance
- Drugs Fluvoxamine (Primary)
- Indications Obsessive-compulsive disorders
- Focus Therapeutic Use
- 07 Oct 2011 New trial record